Search results
Your search for ���������������������������������������������:kn39��� returned no results
Showing 91 to 105 of 763 results for ���������������������������������������������:know���
Showing 91 to 105 of 763 results for ���������������������������������������������:know���
We are listening to your views on this Health technology evaluation. Comments close 25 September 2024.
retropubic mesh sling than after the other operations. It is not possible to know for sure what will happen to any individual woman 4...
NICE guidance on the benefits of implementing
information about the options. They cover the things most women may want to know about. On page 9 you can write down how you feel about...
Find out about the progress made by the health and care system in implementing NICE guidance on cardiovascular disease management
A quick guide for practitioners supporting people growing older with learning disabilities.
Burosumab for treating X-linked hypophosphataemia in children and young people (HST8)
Evidence-based recommendations on burosumab (Crysvita) for X-linked hypophosphataemia in children and young people.
NICE quick guide - moving between hospital and home, including care homes
Join Nice's Public Involvement Programme expert panel
Unintentional injuries: prevention strategies for under 15s (PH29)
This guideline covers strategies, regulation, enforcement, surveillance and workforce development in relation to preventing unintentional injuries in the home, on the road and during outdoor play and leisure.
Abortion care. Patient decision aid on choosing between medical or surgical abortion before 14 weeks
information about the options. They cover the things most women may want to know about. On page 10 you can write down how you feel about...
Tell us about an interventional procedure you think should be assessed by NICE.
do to reduce your risk of bowel and other cancers. It is not possible to know in advance what will happen to any one person. c NICE...
Social care for older people with multiple long-term conditions (QS132)
This quality standard covers the planning and delivery of social care and support for older people (aged 65 and over) with multiple long-term conditions. It includes people living in their own homes, in specialist settings or in care homes, both those who receive support with funding for their social care and those who do not. It describes high-quality care in priority areas for improvement.
View quality statements for QS132Show all sections
Sections for QS132
- Quality statements
- Quality statement 1: Including physical and mental health needs in a care and support needs assessment
- Quality statement 2: Discussing services that could help at a care and support needs assessment
- Quality statement 3: Named care coordinator
- Quality statement 4: Care planning
- Quality statement 5: Review of health and social care plan
- About this quality standard
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanoma (TA766)
Evidence-based recommendations on pembrolizumab (Keytruda) for adjuvant treatment of completely resected stage 3 melanoma in adults.